Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Nurix therapeutics, inc. symbols : SNY save search
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: 18.35%
H: 1.98%
C: -5.88%
first update therapeutics financial results
Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6
Published: 2024-04-09 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: -0.38%
H: 0.95%
C: 0.83%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
protein collaboration extension therapeutics sanofi
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update
Published: 2024-02-15 (Crawled : 21:00) - globenewswire.com
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: -1.59%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: -6.09%
H: 9.95%
C: 6.7%
year update therapeutics financial results
Nurix Therapeutics Outlines 2024 Strategic Priorities with Advancement of Targeted Protein Modulation Pipeline in Cancer and Autoimmune Diseases
Published: 2024-01-08 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: 2.07%
H: 0.48%
C: 0.48%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: 0.0%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: -1.01%
H: 2.76%
C: 1.94%
cancer pipeline protein therapeutics
Nurix Therapeutics Reports Third Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
Published: 2023-10-12 (Crawled : 20:00) - globenewswire.com
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: 2.57%
H: 1.56%
C: -0.31%
update therapeutics financial results
Nurix Therapeutics Reports Second Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
Published: 2023-07-13 (Crawled : 20:00) - globenewswire.com
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: 7.54%
H: 6.83%
C: -9.96%
update therapeutics financial results
Nurix Therapeutics Reports First Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
Published: 2023-04-13 (Crawled : 22:00) - biospace.com/
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: 1.78%
H: 11.56%
C: 10.47%
update therapeutics financial results
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides a Corporate Update
Published: 2023-02-09 (Crawled : 22:00) - globenewswire.com
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: -1.39%
H: 0.0%
C: 0.0%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: -1.87%
H: 6.9%
C: 5.72%
year therapeutics financial update results
Nurix Therapeutics Advances Promising Targeted Protein Modulation Pipeline and Outlines 2023 Strategic Priorities
Published: 2023-01-09 (Crawled : 14:00) - globenewswire.com
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: -8.06%
therapeutics
Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update
Published: 2022-07-07 (Crawled : 21:00) - biospace.com/
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: -1.83%
H: 0.0%
C: -1.19%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 0.38%
H: 0.64%
C: 0.24%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: -0.42%
H: 9.05%
C: 7.65%
therapeutics update results
Nurix Therapeutics Reports Fiscal First Quarter 2022 Financial Results and Provides a Corporate Update
Published: 2022-04-07 (Crawled : 21:00) - biospace.com/
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: 4.21%
H: 0.0%
C: -0.61%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 1.74%
H: 0.0%
C: 0.0%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: -0.36%
H: 3.85%
C: -3.7%
therapeutics results
Kim Trahan
Published: 2021-11-15 (Crawled : 20:00) - nurixtx.com
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: -1.34%
H: 0.92%
C: -1.51%
BioSpace Movers & Shakers, Oct. 22
Published: 2021-10-22 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: -0.41%
LLY | News | $750.77 0.54% 0.22% 2.8M
|
Health Technology
|
| O: -0.09%
H: 1.28%
C: 1.16%
ABT | News | $105.9 -3.03% 0.38% 11M
|
Health Technology
|
| O: 0.37%
H: 1.06%
C: 0.96%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
OCUL | $7.58 -2.7% -2.77% 980K
|
Health Technology
|
| O: -27.15%
H: 0.89%
C: -12.42%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: 0.43%
H: 0.11%
C: -0.81%
GILD | $66.93 -0.57% -0.55% 3.8M
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
space spac
Nurix Therapeutics Reports Third Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
Published: 2021-10-14 (Crawled : 21:00) - globenewswire.com
VRTX | $393.1 -0.27% -0.27% 620K
|
Health Technology
|
| O: 0.32%
H: 0.37%
C: -0.39%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.24%
H: 2.56%
C: 1.25%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: -0.35%
H: 1.12%
C: 0.89%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: 0.91%
H: 1.23%
C: 0.24%
financial results results
Nurix Therapeutics Reports Second Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
Published: 2021-07-13 (Crawled : 21:00) - globenewswire.com
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: -0.19%
H: 0.63%
C: 0.33%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: -0.3%
H: 1.06%
C: -1.94%
financial results results
Nurix Therapeutics Reports First Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
Published: 2021-04-13 (Crawled : 21:00) - globenewswire.com
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 0.56%
H: 0.18%
C: -0.4%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: -0.11%
H: 21.71%
C: 13.04%
financial results results
Nurix Therapeutics Announces Expansion of its Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degradation TherapiesExpansion of agreement results in an additional payment of $22 million to Nurix
Published: 2021-01-07 (Crawled : 19:00) - biospace.com/
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: -0.27%
H: 0.44%
C: 0.44%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: 0.52%
H: 15.42%
C: 14.2%
collaboration expansion
Nurix Therapeutics Announces Expansion of its Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degradation Therapies
Published: 2021-01-07 (Crawled : 12:01) - globenewswire.com
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: -0.27%
H: 0.44%
C: 0.44%
NRIX 1 d | $14.08 -3.89% -3.9% 780K
|
Health Technology
|
| O: 0.52%
H: 15.42%
C: 14.2%
collaboration expansion therapy
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.4848 7.49% 24.58% 5.9M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
KZIA | $0.3442 18.28% 23.42% 290K
|
Health Technology
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.